Literature DB >> 16682830

Endothelial dysfunction in subjects with subclinical hyperthyroidism.

E Coban1, M Aydemir, G Yazicioglu, M Ozdogan.   

Abstract

Numerous clinical and experimental reports suggest that a high von Willebrand factor (vWf) level reflects endothelial damage or endothelial dysfunction. The present study was designed to evaluate vWf in subclinical hyperthyroidic subjects compared with euthyroidic subjects. We selected 20 subclinical hyperthyroidic subjects and 20 euthyroidic control subjects matched for age, gender and body mass index. The level of vWf was significantly higher in the subclinical hyperthyroidic group than in the euthyroidic group (42.9+/-9.6 vs 37.6+/-6.4%, p=0.026). In conclusion, our results suggest that subjects with subclinical hyperthyroidism tend to have an endothelial dysfunction. Endothelial dysfunction could contribute to increasing the cardiovascular risk in subclinical hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682830     DOI: 10.1007/BF03345539

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Mortality in elderly patients with subclinical hyperthyroidism.

Authors:  B Biondi; E A Palmieri; S Filetti; G Lombardi; S Fazio
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Authors:  J Auer; P Scheibner; T Mische; W Langsteger; O Eber; B Eber
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

4.  Blood coagulation and fibrinolysis in patients with hyperthyroidism.

Authors:  C Erem; H O Ersoz; S S Karti; K Ukinç; A Hacihasanoglu; O Değer; M Telatar
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

5.  Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism.

Authors:  M Petretta; D Bonaduce; L Spinelli; M L Vicario; V Nuzzo; F Marciano; P Camuso; V De Sanctis; G Lupoli
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

6.  [Markers of endothelial stimulation in hyperthyroidism].

Authors:  D Rość; W Drewniak; E Zastawna; R Paczuski; A Graczykowska-Koczorowska
Journal:  Pol Merkur Lekarski       Date:  1999-02

7.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.

Authors:  J V Parle; P Maisonneuve; M C Sheppard; P Boyle; J A Franklyn
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

Review 8.  Effects of subclinical thyroid dysfunction on the heart.

Authors:  Bernadette Biondi; Emiliano A Palmieri; Gaetano Lombardi; Serafino Fazio
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

9.  Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol.

Authors:  J Burggraaf; S Lalezari; J J Emeis; U M Vischer; P H de Meyer; H Pijl; A F Cohen
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

10.  Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism.

Authors:  Ayse S Cikim; Huseyin Oflaz; Nese Ozbey; Kerim Cikim; Sabahattin Umman; Mehmet Meric; Ergin Sencer; Senay Molvalilar
Journal:  Thyroid       Date:  2004-08       Impact factor: 6.568

View more
  7 in total

1.  Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism.

Authors:  Oktay Bilgir; Ferda Bilgir; Tuba Topcuoglu; Mehmet Calan; Ozlem Calan
Journal:  Endocrine       Date:  2013-06-19       Impact factor: 3.633

2.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

3.  The thyroid hormone, parathyroid hormone and vitamin D associated hypertension.

Authors:  Sandeep Chopra; Davis Cherian; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2011-10

4.  The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension.

Authors:  Mustafa Karaca; Erkan Coban; Sebahat Ozdem; Mustafa Unal; Ozan Salim; Orhan Yucel
Journal:  Med Sci Monit       Date:  2014-01-19

5.  Effects of a catechins-enriched diet associated with moderate physical exercise in the prevention of hypertension in spontaneously hypertensive rats.

Authors:  Cristina Del Seppia; Giuseppe Federighi; Dosminga Lapi; Federico Gerosolimo; Rossana Scuri
Journal:  Sci Rep       Date:  2022-10-15       Impact factor: 4.996

6.  The changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism.

Authors:  Anna Popławska-Kita; Katarzyna Siewko; Beata Telejko; Anna Modzelewska; Janusz Myśliwiec; Robert Milewski; Maria Górska; Małgorzata Szelachowska
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

Review 7.  Hemostasis in Overt and Subclinical Hyperthyroidism.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.